The 'Singham' Stays Put: Where Tukaram Mundhe's 2026 Transfer Saga Actually Stands

News graphic featuring IPS officer Tukaram Mundhe with Mumbai landmarks, Indian flag and police symbols, highlighting his 2026 transfer controversy and continued Mumbai posting.

TL;DR

  • As of August 19, 2026, IAS officer Tukaram Mundhe has NOT been transferred out of his current post — he remains Maharashtra's Food and Drug Administration (FDA) Commissioner, a role he assumed on May 25, 2026 after the state's General Administration Department (GAD) issued transfer orders on Tuesday, May 19, 2026. The "2026 transfer" story is really two things: his own frequent-transfer record (25 moves in 21 years) and an intense, ongoing lobbying campaign to have him removed that the government has so far publicly resisted.
  • The developments that DID happen in August 2026 are not a transfer but an escalating enforcement drive — Mundhe's FDA issued "final warning" show-cause notices to Shah Rukh Khan, Ajay Devgn and Tiger Shroff (Aug 11) over the "Vimal Elaichi" ad, suspended dozens of licences, and was sharply rebuked by the Bombay High Court in a Pune sweet-shop case (Aug 18-19), even as cross-party MLAs and consumer groups rallied to keep him in the job.
  • The last actual administrative change was subtractive and minor: on June 23, 2026 he was stripped of his ADDITIONAL charge as Parbhani Guardian Secretary (replaced by Dr Chandrakant Pulakundwar), a move widely read as political friction — but he retained the FDA commissionership.

Key Findings

  1. No August 2026 transfer of the FDA post. Multiple sources dated after August 15, 2026 (Business Today, Aug 19; The Week, Aug 17; Business Standard, Aug 17) confirm Mundhe is still actively functioning as FDA Commissioner. Any article headlined around his "transfer" refers to his career-long record or to transfer speculation, not a fresh order.
  2. His current posting resulted from a May 19, 2026 GAD order. He took charge May 25, 2026. This was his 25th transfer in 21 years of service. It followed a stalled April 2026 posting to Disaster Management/Revenue that was put on hold, leaving him without a posting for roughly a month.
  3. The transfer INTO FDA was itself unusual — several officials viewed placing a Secretary-rank officer as a Commissioner as a step down, and it came "amid recent controversies surrounding the department, including allegations of bribery involving a minister's office staff and circulation of objectionable video clips linked to a minister" (Free Press Journal).
  4. A documented lobbying effort to transfer him exists. On June 24, 2026, in the Assembly, NCP (SP) MLA Jitendra Awhad alleged an "international drug lobby" was mobilising money to get Mundhe transferred. FDA Minister Narhari Zirwal assured the House Mundhe would NOT be transferred.
  5. Background is well documented: 2005-batch Maharashtra cadre, AIR 20 in the UPSC exam, born June 3, 1975 in Tadsonna, Beed district, into a marginal-farmer family. Best Collector Award 2015-16 (Solapur), "Waterman of Maharashtra."

Details

1. The latest status: post, dates, and the order

Tukaram Haribhau Mundhe (officer ID 01MH047900) is, as of August 19, 2026, the Commissioner of the Food and Drug Administration (FDA), Maharashtra. He was appointed via a General Administration Department (GAD / Samanya Prashasan Vibhag) order issued on Tuesday, May 19, 2026, and took charge on May 25, 2026.

  • Transferred FROM: He had been left "awaiting posting." In late March/April 2026 he was transferred as Secretary, Disaster Management, Relief, Rehabilitation, Revenue and Forest Department (his 24th posting, per a PTI report of March 31, 2026) — but that order was reportedly stayed, leaving him effectively without an active posting for nearly a month. Immediately before that he was Secretary, Divyang (Persons with Disabilities) Welfare Department (posted August 2025).
  • Transferred TO: Commissioner, FDA Maharashtra (his 25th transfer).
  • Order number and signatory: The exact GR/notification number and the name of the signing official (Deputy/Under Secretary in GAD) are not publicly available; no accessible trusted source reproduced the order's reference number, and the order document could not be located on the GAD portal. This should be flagged as unverified rather than invented.
  • Officers moved in the same order: Reports conflict — Free Press Journal says "six IAS officers," while Indian Masterminds and Pune Pulse frame it as four (the difference appears to hinge on whether additional-charge assignments are counted). Named in the same reshuffle: outgoing FDA chief Shridhar Dube → CEO, MMR Slum Rehabilitation Authority, Thane; Kanhuraj Bagate → MD, Maha Mumbai Metro/MMRCL; Babasaheb Beldar → CEO, Dhule Zilla Parishad; R.S. Chavan → MD, Haffkine Bio-Pharmaceutical Corporation; Sanjay Khandare (ACS, Tourism) → additional charge as Secretary/ACS, FDA.

2. Context and reasons — the transfer that keeps NOT happening

The dominant 2026 storyline is not that Mundhe was transferred, but that powerful interests have been trying to get him transferred and have so far failed.

  • The lobbying allegation: On June 24, 2026, during a calling-attention motion, NCP (SP) MLA Jitendra Awhad told the Assembly: "I fear he will not survive in the position for long as drug companies have started lobbying for his transfer and Rs 250 crore is being accumulated for the purpose." He congratulated Mundhe for daring "to take action against people pushing citizens towards life-threatening diseases like cancer" and warned that even the concerned minister could lose his portfolio for backing him.
  • Government's public stance: FDA Minister Narhari Zirwal "assured the House that Mundhe would not be transferred and appealed to elected representatives to support him."
  • The Parbhani removal (June 23, 2026): GAD replaced Mundhe as Parbhani Guardian Secretary (an additional charge held since February 2026) with Dr Chandrakant Pulakundwar (2008 batch). "No reason was mentioned in the order" (PTI). One explanation offered was technical — that heading an independent commissionerate made him structurally unsuited to the guardian-secretary role — but the timing fed speculation of political friction. He retained the FDA post.
  • What triggered the friction: His aggressive enforcement. Since May 25, the FDA has run one of the state's largest food-safety drives ("Safe Food, Safe Drugs, Safe Maharashtra") — over 1,100 inspections; seizures of adulterated milk, dairy, edible oil, gutkha and pan masala; licence suspensions of iconic Mumbai establishments (Noor Mohammadi Hotel, Shalimar Restaurant, K. Rustom & Co., Cricket Club of India, Willingdon Sports Club, Juhu Gymkhana); and action against quick-commerce dark stores. During a special drive on August 13, the FDA inspected 86 dark stores and suspended 14 food-business licences — "five belonged to Blinkit establishments, five to Zepto, two to Instamart, one to Bhagwati Stores and one to Swinsta Ent Pvt Ltd" — issuing 60 improvement notices; per PTI, "No licence was cancelled during the drive." Zirwal told the Assembly the department "seized food items worth Rs 11.93 crore between May 1 and June 21, including adulterated milk, dairy products, edible oil, drinking water, jaggery, tea powder, mango ripening agents and banned products such as gutkha, tobacco and mawa."
  • Tenure in previous posting: His stalled Disaster Management posting lasted only weeks; before that Divyang Welfare (~8 months, Aug 2025–early 2026). The pattern of sub-year tenures is career-long.

3. Background

  • Batch/cadre: 2005-batch IAS, Maharashtra cadre; cleared UPSC with All India Rank 20. Educated at a Zilla Parishad school in Beed; BA (History) and MA (Political Science), Dr Babasaheb Ambedkar Marathwada University, Aurangabad.
  • Transfers: Widely reported as 25 in 21 years (some databases count 27 distinct postings). Longest single tenure: about 2 years 2 months as Joint Commissioner, Sales Tax, Mumbai.
  • Major postings: Solapur Collector (water conservation under Jalyukt Shivar; "Waterman of Maharashtra"; Best Collector Award 2015-16); Navi Mumbai Municipal Commissioner (2016-17, faced a no-confidence motion); Chairman & MD, PMPML Pune (2017-18); Nashik Municipal Commissioner (2018); Nagpur Municipal Commissioner (2020, led COVID response); Health Commissioner (2022, brief); Divyang Welfare Secretary (2025-26); FDA Commissioner (2026-present).
  • Reputation: "Singham" of the bureaucracy; honest, rules-first, no-nonsense. Critics say his style is rigid/autocratic; a PMPML board member once called him "100 percent honest… but he causes more harm… with his arrogance and his tendency to take unilateral decisions."
  • Awards: Best Collector Award 2015-16; recognition as "Waterman of Maharashtra"; and other honours cited in profiles (National Award for Social Justice and Empowerment; SKOCH Order of Merit for Navi Mumbai; a national traffic-management recognition).
  • Controversies/clashes: No-confidence motions in Navi Mumbai and Nashik; a public dispute with then Revenue Minister Eknath Khadse during the 2015 Ashadhi Wari; Ajit Pawar's Assembly criticism that he disrespected elected representatives; an FIR over an alleged lockdown-restriction violation and a harassment complaint from a former officer.

4. Reactions

  • Politicians: Cross-party support in the Assembly (June 24) — MLAs Kashinath Date (Shiv Sena), Sudhir Mungantiwar (BJP), Nana Patole (Congress), Abhijit Patil, Rais Shaikh, Prashant Bamb, Atul Bhatkhalkar and others backed him. Deputy CM Ajit Pawar was more ambivalent — he suggested Mundhe be made head of the state's anti-narcotics squad ("Mr Mundhe is taking pan masala so seriously; he will take drugs equally seriously") while also questioning the "disproportionate media attention": "Only one officer is seen in the media. Does that mean the other officers are not working?"
  • Citizens/civil society: The Akhil Bharatiya Grahak Panchayat (Pune) warned the government against transferring him and announced a signature campaign; supporters in Sangli protested against a possible transfer. At a Pune event ("Unstoppable Tukaram") at Bal Gandharva Rang Mandir, he received a standing ovation.
  • Social media: Nicknamed "Singham"/"real-life Singham"; viral videos praising cleaner street-food stalls; industrialist Harsh Goenka publicly praised him as "an honest officer India needs more of." Support coalesced around the "Unstoppable Tukaram" framing.
  • Media tone: Largely admiring nationally (Gulf News called him a "social media hero"), with more sceptical business/consumer coverage. The Week, citing a LocalCircles survey (Aug 17), reported "just one in ten consumers having high trust in their respective district or state FDAs," with the "highest trust levels… seen in Mumbai with 36 per cent, while it plummeted to just 8 per cent in Delhi" — a caution that public enthusiasm has outrun measurable ground-level trust.
  • Legal: The Bombay High Court questioned immediate licence suspensions, told the FDA to take a "realistic view," and ordered uniform enforcement across private AND government establishments (leading to inspections of court and Mantralaya canteens). In the Pune sweet-shop case (Gurunanak Dairy and Sweets, found 98% compliant on July 13 re-inspection but shut for 34 days), the bench of Acting Chief Justice Ravindra V. Ghuge and Justice Gautam A. Ankhad said on Aug 18: "This is plain and simple perversity. Absolute strange policies… Once you clear with 98%, you say, now, go and file an appeal. What is this? Torturing citizens." The court set aside the suspension and directed the FDA to pay Rs 5 lakh. Mundhe (Aug 19): "It was a case of food poisoning, and those who consumed the sweets were hospitalised, and the report is 'unsafe'. So, the action we took was correct… We stand by what we say."
  • On the Bollywood notices: Per Daily Pioneer/PTI, the Aug 11 notice from FDA's Greater Mumbai division to Shah Rukh Khan, Ajay Devgn and Tiger Shroff was over the "Vimal Elaichi" advertisement, terming it a "final warning" that "prima facie amounts to 'indirect or surrogate' promotion of prohibited pan masala," and gave the three actors 15 days to respond.

5. Impact

  • On the department: Mundhe has transformed a regulator long criticised for sluggishness into an aggressive enforcement body ("the Mundhe effect"). Minister Zirwal admitted infrastructure is inadequate — per PTI, he said "as against 200 sanctioned posts of drug inspectors, only 41 officers are currently in service," while "Maharashtra requires around 1,100 food safety officers and 400 drug inspectors." New labs and PPP tie-ups (22 accredited labs, cutting report time from 90 to 30-35 days) are being pursued.
  • Pending reforms at risk if he moves: Lab modernisation, staffing, the schools junk-food ban, and systemic anti-adulteration mechanisms — historically his reforms lose momentum after he leaves.
  • What people expect next: Given his record of sub-year tenures, observers openly speculate he "will not complete even a year." His supporters and consumer groups are pre-emptively mobilising to keep him.
  • Signal of this episode: The government publicly committing (via Zirwal) not to transfer him, plus visible public backing, marks a rare instance where the usual "reform-friction-transfer" cycle has, at least for now, been interrupted — even as the Parbhani removal shows continued low-grade friction.


Caveats

  • Exact GR number and signatory are unconfirmed. No trusted source published the order's reference number or the signing official; do not fabricate one.
  • The 25-transfer figure is journalistic shorthand — some official databases list 27 postings; "25 transfers" is the widely cited number and should be attributed, not stated as precise.
  • Four-vs-six officers in the May order is a genuine source conflict (definitional — full transfers vs additional-charge assignments).
  • The Rs 250 crore lobbying claim is an allegation by one MLA (Jitendra Awhad), not a proven fact; attribute it clearly.
  • Some circulating write-ups are lower-tier blogs/aggregators; the core facts here are corroborated by PTI, Free Press Journal, ThePrint, Business Today, Business Standard, Daily Pioneer, Deccan Herald and Gulf News.
  • Dates reflect reporting available up to August 19, 2026; a transfer could occur after this date, so verify status immediately before publishing.

Share this story

How do you feel about this story?

Comments

viki said…
we love these kind of honest officers